CGRP-hämmare (Swedish Wikipedia)

Analysis of information sources in references of the Wikipedia article "CGRP-hämmare" in Swedish language version.

refsWebsite

Global rank Swedish rank

5fda.gov

447^th place

1,667^th place

5fass.se

low place

112^th place

2web.archive.org

1^st place

2doi.org

2^nd place

14^th place

2nih.gov

4^th place

17^th place

1medicalxpress.com

8,255^th place

low place

1janusinfo.se

low place

1,385^th place

1ajmc.com

low place

1americanmigrainefoundation.org

low place

1mynewsdesk.com

4,342^nd place

49^th place

1tevacare.se

low place

1lilly.com

low place

1americanheadachesociety.org

low place

ajmc.com

”FDA Approves Erenumab, First CGRP Inhibitor for Prevention of Migraine”. AJMC. https://www.ajmc.com/newsroom/fda-approves-erenumab-first-cgrp-inhibitor-for-prevention-of-migraine. Arkiverad 24 februari 2019 hämtat från the Wayback Machine.

americanheadachesociety.org

”Eptinezumab-jjmr (VYEPTI™) Approved By FDA for Migraine Prevention” (på amerikansk engelska). American Headache Society. https://americanheadachesociety.org/news/eptinezumab-vyepti-approved-by-fda/.

americanmigrainefoundation.org

”FDA Approves Second Anti-CGRP Treatment for Migraine”. American Migraine Foundation. https://americanmigrainefoundation.org/resource-library/fda-approves-second-anti-cgrp-treatment-for-migraine/.

doi.org

dx.doi.org

Mitsikostas, DD; Reuter, U (2017). ”Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: comparisons across randomized controlled studies”. Curr Opin Neurol 30 (3): sid. 272–280. doi:10.1097/WCO.0000000000000438. PMID 28240610.
”TRPV1 pain receptors regulate longevity and metabolism by neuropeptide signaling”. Cell 157 (5): sid. 1023–1036. 2014. doi:10.1016/j.cell.2014.03.051. PMID 24855942.

fass.se

”Fass vårdpersonal - Vydura”. https://www.fass.se/LIF/product?nplId=20210212000017&userType=0. Läst 4 november 2022.
”Fass Vårdpersonal - Aimovig”. https://www.fass.se/LIF/product?nplId=20170524000047&userType=0. Läst 1 augusti 2024.
”Fass vårdpersonal - Vyepti”. https://www.fass.se/LIF/product?nplId=20201117000035&userType=0. Läst 1 augusti 2024.
”Fass Vårdpersonal - Ajovy”. https://www.fass.se/LIF/product?nplId=20200114000086&userType=0. Läst 1 augusti 2024.
”Fass vårdpersonal - Emgality”. https://www.fass.se/LIF/product?nplId=20171027000060&userType=0. Läst 1 augusti 2024.

fda.gov

accessdata.fda.gov

janusinfo.se

”Tre CGRP-hämmare jämställs vid migrän”. TLV. Arkiverad från originalet den 6 november 2022. https://web.archive.org/web/20221106142827/https://janusinfo.se/nationelltinforandeavlakemedel/nyheter/nyheter/trecgrphammarejamstallsvidmigran.5.759da6c1177103a284ac2f2.html. Läst 1 augusti 2024.

lilly.com

investor.lilly.com

”Lilly's Emgality™ (galcanezumab-gnlm) Receives U.S. FDA Approval for the Preventive Treatment of Migraine in Adults”. Eli Lilly and Company. https://investor.lilly.com/news-releases/news-release-details/lillys-emgalitytm-galcanezumab-gnlm-receives-us-fda-approval.

medicalxpress.com

”How the germ behind flesh-eating disease hijacks neurons to avoid immune destruction”. How the germ behind flesh-eating disease hijacks neurons to avoid immune destruction. https://medicalxpress.com/news/2018-05-germ-flesh-eating-disease-hijacks-neurons.html.

mynewsdesk.com

”Pressmeddelande”. Mynewsdesk. https://www.mynewsdesk.com/se/teva-sweden/pressreleases/tevas-ajovy-r-faar-eu-godkaennande-vilket-erbjuder-patienter-den-foersta-och-enda-anti-cgrp-behandlingen-med-baade-kvartals-och-maanadsvis-dosering-foer-dot-dot-dot-2854852. Läst 1 augusti 2024.

nih.gov

ncbi.nlm.nih.gov

Mitsikostas, DD; Reuter, U (2017). ”Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: comparisons across randomized controlled studies”. Curr Opin Neurol 30 (3): sid. 272–280. doi:10.1097/WCO.0000000000000438. PMID 28240610.
”TRPV1 pain receptors regulate longevity and metabolism by neuropeptide signaling”. Cell 157 (5): sid. 1023–1036. 2014. doi:10.1016/j.cell.2014.03.051. PMID 24855942.

tevacare.se

”Ajovy verkningsmerkanism”. Teva care. https://www.tevacare.se/migraen/ajovy/verkningsmekanism. Läst 1 augusti 2024.

web.archive.org

”Tre CGRP-hämmare jämställs vid migrän”. TLV. Arkiverad från originalet den 6 november 2022. https://web.archive.org/web/20221106142827/https://janusinfo.se/nationelltinforandeavlakemedel/nyheter/nyheter/trecgrphammarejamstallsvidmigran.5.759da6c1177103a284ac2f2.html. Läst 1 augusti 2024.
”FDA Approves Erenumab, First CGRP Inhibitor for Prevention of Migraine”. AJMC. https://www.ajmc.com/newsroom/fda-approves-erenumab-first-cgrp-inhibitor-for-prevention-of-migraine. Arkiverad 24 februari 2019 hämtat från the Wayback Machine.